159 related articles for article (PubMed ID: 9171069)
1. Multiple myeloma.
Bataille R; Harousseau JL
N Engl J Med; 1997 Jun; 336(23):1657-64. PubMed ID: 9171069
[No Abstract] [Full Text] [Related]
2. Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-alpha and erythropoietin.
Hiyoshi M; Hashimoto S; Ota T; Nakao T; Takubo T; Tagawa S; Tatsumi N
Haematologia (Budap); 1997; 28(3):177-80. PubMed ID: 9283919
[TBL] [Abstract][Full Text] [Related]
3. Transient response of myeloma clone to pamidronate therapy.
Corso A; Astori C; Orlandi E; Zappasodi P; Arcaini L; Bernasconi C
Haematologica; 1999 Aug; 84(8):759-60. PubMed ID: 10457421
[No Abstract] [Full Text] [Related]
4. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma.
Ararat E; Sahin I; Ozdemir E; Altundag K
Br J Haematol; 2010 Dec; 151(5):530-1. PubMed ID: 20880117
[No Abstract] [Full Text] [Related]
5. Interferon does not prevent leukemic evolution in patients with multiple myeloma.
Remes K; Paul R; Pelliniemi TT
Leukemia; 1993 Jul; 7(7):1072-3. PubMed ID: 8321024
[No Abstract] [Full Text] [Related]
6. [Antithrombin activity in multiple myeloma].
Baele G; Hamers J; Van Hove W
Acta Clin Belg; 1974; 29(6):394-9. PubMed ID: 4440399
[No Abstract] [Full Text] [Related]
7. New agents for the treatment of multiple myeloma and non-Hodgkin lymphoma.
Oken MM
Cancer; 1992 Aug; 70(4 Suppl):946-8. PubMed ID: 1638466
[TBL] [Abstract][Full Text] [Related]
8. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
[No Abstract] [Full Text] [Related]
9. [Current therapy concepts in patients with multiple myeloma].
Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
[No Abstract] [Full Text] [Related]
10. [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
García Laraña J; Díaz Mediavilla J; Martínez R; Lahuerta JJ; Alegre A; Odriozola J; Sureda A; San Miguel J; De la Rubia J; Escudero A; Conde E; Bladé J; Cabrera R; Gastearena J; Besalduch J; Vidal MJ; Hernández F; Rifon J; Leon A; Mataix R; Parody R; Moraleda JM; Solano C; de Pablos JM; Sánchez JJ
Sangre (Barc); 1997 Apr; 42 Suppl 1():38-41. PubMed ID: 9381300
[No Abstract] [Full Text] [Related]
11. Geraldine Ferraro. The fight of her life. Interview by Jo Cavallo.
Ferraro G
InTouch; 2002 Sep; 4(5):24-6, 33. PubMed ID: 12398056
[No Abstract] [Full Text] [Related]
12. The role of alpha-interferon in multiple myeloma.
Peest D
Pathol Biol (Paris); 1999 Feb; 47(2):172-7. PubMed ID: 10192884
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma and renal failure.
Goldschmidt H; Lannert H; Bommer J; Ho AD
Nephrol Dial Transplant; 2000 Mar; 15(3):301-4. PubMed ID: 10692511
[No Abstract] [Full Text] [Related]
14. [Prognostic factors and standard therapy of multiple myeloma].
Peest D
Praxis (Bern 1994); 1998 Jun; 87(25-26):874-8. PubMed ID: 9702090
[TBL] [Abstract][Full Text] [Related]
15. Morphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment.
Zhang PL; Quiery AT; Blasick TM; Brown RE
Ann Clin Lab Sci; 2007; 37(1):34-8. PubMed ID: 17311867
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: an update of developments in targeted therapy.
Hussein MA
Expert Rev Anticancer Ther; 2005 Apr; 5(2):379-89. PubMed ID: 15877532
[TBL] [Abstract][Full Text] [Related]
17. IgE response in multiple myeloma.
Tamir R; Barchat I; Weiss H; Pick AI
Ann Allergy; 1993 Mar; 70(3):214-7. PubMed ID: 8452316
[TBL] [Abstract][Full Text] [Related]
18. [IgA multiple myeloma with adverse prognostic factors--a case report].
Kumiega B; Wolska-Smoleń T; Skotnicki AB
Przegl Lek; 2009; 66(8):459-63. PubMed ID: 20043594
[TBL] [Abstract][Full Text] [Related]
19. IgA multiple myeloma responding to erythropoietin monotherapy.
Barrios M; Alliot C
Am J Hematol; 2005 Oct; 80(2):165-6. PubMed ID: 16184582
[No Abstract] [Full Text] [Related]
20. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
